Notice of Proposed Sale · 144
Johnson & Johnson
JNJNYSEEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- JOHNSON & JOHNSON
- Issuer CIK
- 0000200406
- SEC file number
- 001-03215
- Phone
- 732-524-2455
- Person for whose account securities are to be sold
- Duato Joaquin
- Relationships to issuer
- Officer · Director
- Street
- ONE JOHNSON & JOHNSON PLZ
- City
- NEW BRUNSWICK
- State / country code
- NJ
- Postal code
- 08933
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common | 123,291 | 32,199,927.00 | 2,409,898,597 | 08/13/2026 | NYSE | Fidelity Brokerage Services LLC |
Broker / market maker — proposed row 1, entry 1
- Name
- Fidelity Brokerage Services LLC
- Street
- 900 Salem Street
- City
- Smithfield
- State / country code
- RI
- Postal code
- 02917
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 08/13/2026 | Stock Option Exercise | Issuer | 123,291 | N | 08/13/2026 | Cash |
Sales reported in the preceding three months
| Seller | Security | Sale date | Amount sold | Gross proceeds |
|---|---|---|---|---|
| Joaquin Duato | Common | 08/05/2026 | 48,480 | 12,515,010.09 |
Seller — prior-sale row 1, entry 1
- Name
- Joaquin Duato
- Street
- One Johnson & Johnson Plaza
- City
- New Brunswick
- State / country code
- NJ
- Postal code
- 08933
Prior-sale reporting
- Nothing to report for the preceding three months
- N
Notice signature
- Notice date
- 08/13/2026
- Signed
- /s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Joaquin Duato
Company context
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.